ERCC1, XPF and XPA—locoregional differences and prognostic value of DNA repair protein expression in patients with head and neck squamous cell carcinoma

Cancer of the Oropharynx

(2015) David A. Clump et al.   Surgical Oncology Clinics of North America

Epidemiology of Head and Neck Cancer

(2015) Eleni M. Rettig et al.   Surgical Oncology Clinics of North America

DNA Repair Biomarkers XPF and Phospho-MAPKAP Kinase 2 Correlate with Clinical Outcome in Advanced Head and Neck Cancer

(2014) Tanguy Y. Seiwert et al.   PLoS One

Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer in a Chinese population

(2014) Junkai Li et al.   TUMOR BIOLOGY

ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial

(2013) J E Bauman et al.   BRITISH JOURNAL OF CANCER

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection

(2013) Stephanie B. Hatch et al.   INTERNATIONAL JOURNAL OF CANCER

ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer

(2013) Luc Friboulet et al.   NEW ENGLAND JOURNAL OF MEDICINE

ERCC1 Protein Expression Is Associated with Differential Survival in Oropharyngeal Head and Neck Squamous Cell Carcinoma

(2013) Mihir R. Patel et al.   OTOLARYNGOLOGY-HEAD AND NECK SURGERY

Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology

(2012) Donghui Ma et al.   BMC BIOTECHNOLOGY

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prognostic value of ERCC1 in head and neck carcinoma treated with definitive or adjuvant radiotherapy

(2012) Vesna Bišof et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy

(2012) E. M. McNeil et al.   NUCLEIC ACIDS RESEARCH

XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck

(2011) Alec Vaezi et al.   CLINICAL CANCER RESEARCH

Comparing ERCC1 protein expression, mRNA levels, and genotype in squamous cell carcinomas of the head and neck treated with concurrent chemoradiation stratified by HPV status

(2011) Desirée Hao et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area

(2011) Tai-Jan Chiu et al.   Journal of Translational Medicine

Immunodetection of DNA Repair Endonuclease ERCC1-XPF in Human Tissue

(2009) N. R. Bhagwat et al.   CANCER RESEARCH

The XPA-binding domain of ERCC1 Is Required for Nucleotide Excision Repair but Not Other DNA Repair Pathways

(2009) Barbara Orelli et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

(2009) Jean-Pierre Pignon et al.   RADIOTHERAPY AND ONCOLOGY

ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel

(2008) Lifeng Wang et al.   BMC CANCER

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation

(2008) H J Jun et al.   BRITISH JOURNAL OF CANCER

Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

(2008) C. Fakhry et al.   JNCI-Journal of the National Cancer Institute

ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer

(2007) Min Kyoung Kim et al.   EUROPEAN JOURNAL OF CANCER